Comments*

 
  • Academy Events

  • Gene Therapy for Rare Diseases

    Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM
    The New York Academy of Sciences

    Presented by the Biochemical Pharmacology Discussion Group and the New York Academy of Sciences

    Numerous life-threatening rare diseases are due to single gene mutations that manifest within several months of birth. With no effective treatment options, these monogenic diseases require constant and expensive care. Gene therapy is beginning to show clinical promise as a strategy for treating rare diseases, but faces challenges around safe, consistent, and durable gene delivery to targeted tissues. This symposium will explore recent advances in gene therapy for rare diseases, identify issues that remain to be addressed in order for gene therapy to become more widely used, and explore opportunities for application to other disease areas.

    Call for Poster Abstracts

    Abstract submissions are invited for a poster session. For complete submission instructions, please send an email to RareDiseases@nyas.org with the words "Abstract Information" in the subject line. The deadline for abstract submission is March 17, 2017.

    Registration Pricing

    Member $60
    Member (Student / Postdoc / Fellow) $25
    Nonmember (Academia) $105
    Nonmember (Corporate) $160
    Nonmember (Non-profit) $105
    Nonmember (Student / Postdoc / Fellow) $70

    This event also will be broadcast via webinar. Registration is required.

    Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City where possible.

    Webinar Pricing

    Member $30
    Member (Student / Postdoc / Fellow) $15
    Nonmember (Academia) $65
    Nonmember (Corporate) $85
    Nonmember (Non-profit) $65
    Nonmember (Student / Postdoc / Fellow) $45


    The Biochemical Pharmacology Discussion Group is proudly supported by:

    • Boehringer Ingelheim
    • Regeneron

    ACS New York Section


    Premiere Supporter

    • Pfizer
    EmailPrint